Nrf2-Mediated Metabolic Reprogramming in Cancer
Joint Authors
Liu, Xiaoming
Chen, Juan
Wang, Yan-Yang
Zhe, Hong
Zhao, Ren
Source
Oxidative Medicine and Cellular Longevity
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-01-29
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Metabolic reprogramming is one of the hallmarks of cancer.
Nrf2 pathway is one of the critical signaling cascades involved in cell defense and survival against oxidative stress.
The significance of Nrf2 in cancer metabolism begins to be recognized.
In this minireview, we focus on the Nrf2-mediated cancer metabolic reprogramming and intend to highlight the role of Nrf2 in the regulation of malignant transformation, cancer proliferation, and the development of treatment resistance via metabolic adaptations.
We hope for the development of noninvasive biomarkers and novel therapeutic approaches for cancer based on Nrf2-directed cancer metabolic reprogramming in the near future.
American Psychological Association (APA)
Wang, Yan-Yang& Chen, Juan& Liu, Xiaoming& Zhao, Ren& Zhe, Hong. 2018. Nrf2-Mediated Metabolic Reprogramming in Cancer. Oxidative Medicine and Cellular Longevity،Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1212371
Modern Language Association (MLA)
Wang, Yan-Yang…[et al.]. Nrf2-Mediated Metabolic Reprogramming in Cancer. Oxidative Medicine and Cellular Longevity No. 2018 (2018), pp.1-7.
https://search.emarefa.net/detail/BIM-1212371
American Medical Association (AMA)
Wang, Yan-Yang& Chen, Juan& Liu, Xiaoming& Zhao, Ren& Zhe, Hong. Nrf2-Mediated Metabolic Reprogramming in Cancer. Oxidative Medicine and Cellular Longevity. 2018. Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1212371
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1212371